SOPH Q4 2023 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q4 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$17M+27.4% YoY

Gross Profit

$12M69.8% margin

Operating Income

-$19M-111.1% margin

Net Income

-$24M-141.1% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$14M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$206M

Total Liabilities

$55M

Stockholders' Equity

$151M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$13M	+27.4%
Gross Profit	$12M	$10M	+23.6%
Operating Income	-$19M	-$15M	-25.6%
Net Income	-$24M	-$14M	-72.2%

Geographic Segments

Europe, The Middle East And Africa

$33M70%

North America

$8M17%

Latin America

$3M6%

Asia Pacific

$3M6%